Autologous cell therapy is a therapeutic procedure which uses the cells of an individual, which are well-bred and nurtured outside the body and then reintroduced at the site of the disease of the individual. Autologous cell therapy is a new breakthrough in the field of medical history. Autologous cell therapy (ACT) is one of the most rapidly evolving fields due to the revolution in the bioengineering sector since the last few decades.
Previously diseases like Alzheimer’s, Parkinson's were thought to be incurable; however the invention of Autologous cell therapy has changed this belief. The efficient capability of Autologous cell therapy has helped cure many patients recover from such deadly diseases. Owing to its effective treatment procedure, Autologous cell therapy is becoming popular across the globe.
Autologous cell therapy is one of the better alternatives to allogenic stem cell therapy as it avoids any viral infection from a donor. The allogenic cell therapy is a procedure which involves the transplantation of cells from a donor into the patient’s body, which makes the patient vulnerable to the viruses that may be transmitted from the donor’s body. As there is no necessity to find a donor and hardly any risk associated in cross checking the compatibility with the patient’s body, Autologous cell therapy is the most preferred therapy by medical practitioners. Autologous being less risky as compared to allogenic cell therapy is mostly preferred by patients all over the world. This is one of the major driving factors pushing this therapy way ahead.
Diseases like diabetes if treated inappropriately leads to side effects resulting in blindness. Autologous cell therapy proves effective in treatment of such diseases minimizing the risk almost to a negligible level. Medical practitioners across the globe prefer ACT owing to its outstanding results. A few diseases are still incurable by ACT restraining its global market to a certain extent. Such diseases are curable by chemotherapy methods. Most of the B-cell malignancies are not curable and when tested by Autologous cell therapy resulted in failure.
The MCG BMT Autologous Stem Cell Program has been accredited by the Foundation for Accreditation of Cellular Therapy, opening new horizons for the ACT market across the globe. A few debates were under consideration including the curability of neurodegenerative diseases. Such diseases were incurable which were based on the fact that neurons cannot be regenerated in adulthood. This has been proven wrong by certain laboratory experiments carried out in the University of Florida.
ACT has evolved effectively, treating various parts of the human body. The segmentation of ACT depends upon the body parts being treated which include ACT for knees, ACT for arthritis and ACT for hair. ACT may be also segmented based on autoimmune diseases, neurodegenerative conditions, cancer and skin transplantation, cardiovascular, and infectious disease treatments.
The North American ACT market is evolving at an effective growth rate of 18.4% owing to the treatment of various diseases like Ischemic heart failure, Myocardial infarction and diabetes. The ACT market in Latin America is gaining popularity as a result of various skin transplantation procedures and diabetes being effectively cured. Similarly certain other regions like Europe and France are performing research and development in ACT to formulate new techniques in curing diseases which are still not curable. Asia Pacific and Australia are some of the potential markets fuelling the ACT market.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
Browse Upcoming Reports @:http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact us:-
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
No comments:
Post a Comment